Works matching IS 17762596 AND DT 2024 AND VI 19 AND IP 6

Results: 13
    1
    2
    3
    4
    5

    Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective Trial.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 6, p. 957, doi. 10.1007/s11523-024-01095-4
    By:
    • Yılmaz, Feride;
    • Yaşar, Serkan;
    • Mandel, Nil Molinas;
    • Kaçan, Turgut;
    • Özdemir, Melek;
    • Doğu, Gamze Gököz;
    • Şengül, Nilay;
    • Meydan, Nezih;
    • Başal, Fatma Buğdaycı;
    • Tolunay, Pınar Kubilay;
    • Hamamcı, Melda Berber;
    • Dinçer, Oğuz Salih;
    • Bahçeci, Aykut;
    • Özer, Leyla;
    • Ajredini, Miraç;
    • Kırca, Önder;
    • Yersal, Özlem;
    • Can, Orçun;
    • Günaldı, Meral;
    • Demir, Gökhan
    Publication type:
    Article
    6

    Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2<sup>EV</sup> Study.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 6, p. 905, doi. 10.1007/s11523-024-01099-0
    By:
    • Fiala, Ondřej;
    • Massari, Francesco;
    • Basso, Umberto;
    • Giannatempo, Patrizia;
    • Grande, Enrique;
    • Buti, Sebastiano;
    • Myint, Zin W.;
    • De Giorgi, Ugo;
    • Pichler, Renate;
    • Grillone, Francesco;
    • Ürün, Yüksel;
    • Calabrò, Fabio;
    • Bourlon, Maria T.;
    • Galli, Luca;
    • Kanesvaran, Ravindran;
    • Roviello, Giandomenico;
    • Kucharz, Jakub;
    • Rizzo, Mimma;
    • Park, Se Hoon;
    • Cerbone, Linda
    Publication type:
    Article
    7
    8
    9

    Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1).

    Published in:
    Targeted Oncology, 2024, v. 19, n. 6, p. 893, doi. 10.1007/s11523-024-01096-3
    By:
    • Santini, Daniele;
    • Li, Haoran;
    • Roviello, Giandomenico;
    • Park, Se Hoon;
    • Grande, Enrique;
    • Kucharz, Jakub;
    • Basso, Umberto;
    • Fiala, Ondrej;
    • Monteiro, Fernando Sabino Marques;
    • Poprach, Alexandr;
    • Buti, Sebastiano;
    • Molina-Cerrillo, Javier;
    • Catalano, Martina;
    • Buchler, Tomas;
    • Seront, Emmanuel;
    • Ansari, Jawaher;
    • Myint, Zin W.;
    • Ghosn, Marwan;
    • Calabrò, Fabio;
    • Kopp, Ray Manneh
    Publication type:
    Article
    10

    Single-Hit and Multi-hit PIK3CA Short Variant Genomic Alterations in Clinically Advanced Prostate Cancer: A Genomic Landscape Study.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 6, p. 981, doi. 10.1007/s11523-024-01100-w
    By:
    • Basin, Michael F.;
    • Miguel, Carla M.;
    • Jacob, Joseph M.;
    • Goldberg, Hanan;
    • Grivas, Petros;
    • Spiess, Philippe E.;
    • Necchi, Andrea;
    • Kamat, Ashish M.;
    • Pavlick, Dean C.;
    • Huang, Richard S. P.;
    • Lin, Douglas I.;
    • Danziger, Natalie;
    • Sokol, Ethan S.;
    • Sivakumar, Smruthy;
    • Graf, Ryon;
    • Cheng, Liang;
    • Vasan, Neil;
    • Ross, Jeffrey;
    • Basnet, Alina;
    • Bratslavsky, Gennady
    Publication type:
    Article
    11

    Impact of First-Line Osimertinib and Other EGFR-Tyrosine Kinase Inhibitors on Overall Survival in Untreated Advanced EGFR-Mutated Non-small Cell Lung Cancer in Japan: Updated Data from TREAD Project 01.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 6, p. 925, doi. 10.1007/s11523-024-01094-5
    By:
    • Hibino, Makoto;
    • Imamura, Yoshinori;
    • Shimoyama, Rai;
    • Fukui, Tomoya;
    • Fukai, Ryuta;
    • Iwase, Akihiko;
    • Tamura, Yukihiro;
    • Chihara, Yusuke;
    • Okabe, Takafumi;
    • Uryu, Kiyoaki;
    • Okuda, Tadahisa;
    • Taguri, Masataka;
    • Minami, Hironobu
    Publication type:
    Article
    12

    Evaluation of Drug–Drug Interaction Potential of Talquetamab, a T-Cell-Redirecting GPRC5D × CD3 Bispecific Antibody, as a Result of Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model

    Published in:
    Targeted Oncology, 2024, v. 19, n. 6, p. 965, doi. 10.1007/s11523-024-01093-6
    By:
    • Willemin, Marie-Emilie;
    • Gong, Jue;
    • Hilder, Brandi W.;
    • Masterson, Tara;
    • Tolbert, Jaszianne;
    • Renaud, Thomas;
    • Heuck, Christoph;
    • Kane, Colleen;
    • De Zwart, Loeckie;
    • Girgis, Suzette;
    • Ma, Xuewen;
    • Ouellet, Daniele
    Publication type:
    Article
    13